News & Analysis on Clinical Trial Services & Contract Research And Development
Environmental certification of production facilities should be introduced to GMP legislation and sustainability risk assessments linked to marketing authorisations, according to a MPA report.
MDS believes its early stage business is likely to sell for less than previously expected because of the continued deterioration of market conditions and its declining customer base.
Copley Scientific claims new dissolution testing apparatus is first commercially available device specifically designed for inhaled drug formulations.
Schott says its new Russian packaging plant will help meet demand of growing local pharmaceutical market.
Recipharm says acquisition of German CMO Wasserburger Arzneimittelwerk from Hospira adds large-scale lyophilisation services to its offering.
Merck KGaA has begun work on a new inorganic salts plant in Darmstadt, Germany, citing growing demand as the main motivation for the €30m ($42m) investment.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Vasella stepping down as CEO of Novartis and appointments at Shionogi Pharma and Antares Pharma.